GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17761
Submission : 2004-09-28
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17762
Submission : 2004-09-28
Status : Active
Type : IV

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41254
Submission : 2025-04-25
Status : Active
Type : IV

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41749
Submission : 2025-06-20
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28846
Submission : 2014-11-20
Status : Active
Type : IV

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17761
Submission : 2004-09-28
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 17762
Submission : 2004-09-28
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41749
Submission : 2025-06-20
Status : Active
Type : IV

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28846
Submission : 2014-11-20
Status : Active
Type : IV

USDMF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 41254
Submission : 2025-04-25
Status : Active
Type : IV

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FINISHED DOSAGE FORMULATIONS
ISONIAZID; PYRAZINAMIDE; RIFAMPIN
Drug : RIFATER
Dosage Form : TABLET; ORAL
Application Number : 50705
Country : US
Patented : No
Drug : PRIFTIN
Dosage Form : TABLET; ORAL
Application Number : 21024
Country : US
Patented : No
Drug : TRICOR
Dosage Form : TABLET; ORAL
Application Number : 21656
Country : US
Patented : No
PANCRELIPASE (AMYLASE; LIPASE; PROTEASE)
Drug : CREON
Dosage Form : CAPSULE, DELAYED RELEASE; ORAL
Application Number : 20725
Country : US
Patented : No
Drug : URSO FORTE
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : URSO 250
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : ESTRACE
Dosage Form : CREAM; VAGINAL
Application Number : 86069
Country : US
Patented : No
Drug : BYSTOLIC
Dosage Form : TABLET; ORAL
Application Number : 21742
Country : US
Patented : No
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
ACETAMINOPHEN; BUTALBITAL; CAFFEINE; CODEINE PHOSPHATE
Drug : BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE
Dosage Form : CAPSULE; ORAL
Application Number : 76560
Country : US
Patented : No
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]SODIUM LAURYL SULFATE
Route : BUCCAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 5.18
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : BUCCAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 5.18
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : BUCCAL/SUBLINGUAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 1.1
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : DENTAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 1.47
Potency Unit : %

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : DENTAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : INHALATION
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 0
Potency Unit : NA

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : ORAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 25.8
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : ORAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 3.6
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : ORAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 5.08
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
SODIUM LAURYL SULFATE
Route : ORAL
CAS : 151-21-3
UNII : 368GB5141J
Potency Amount : 2
Potency Unit : MG

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
EXCIPIENTS BY APPLICATIONS
MARKET PLACE
Reply
14 Aug 2025
Reply
20 May 2025
Reply
19 May 2025
Reply
01 May 2025
Reply
04 Apr 2025
Reply
06 Mar 2025
Reply
04 Nov 2024
Reply
21 Sep 2024
Reply
10 Sep 2024
Reply
19 Apr 2024
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]		
REF. STANDARDS & IMPURITIES